Pluristem Therapeutics' CEO Letter to Shareholders

HAIFA, Israel, Nov. 22, 2011 (GLOBE NEWSWIRE) -- Dear Shareholders, As we close in on the end of the calendar year, it is important to look back upon all that we at Pluristem have accomplished over the last 12 months, but it is even more crucial to focus the majority of our energies on the challenges and opportunities awaiting Pluristem Therapeutics in 2012 and beyond. Here is a recap of our recent achievements, which have put the company on course for a very successful future.